hotspot -WSS

hotspot

author：leisure time 2025-09-30 14:09:19 - browse：4934

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

explore

WSS

STAT Virtual Event: JPM Recap, Live!

Medicare Advantage coverage denials need scrutiny, senators say

Physician assistants need a new name. Here's what it should be

Fauci's latest grilling in Congress: 9 hours, behind closed doors

FDA early review: GLP

Allen Institute goes after foundational questions, CEO Costa says

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Moonlake's readout produced a cash windfall. Risks remain

FDA early review: GLP

Moonlake's readout produced a cash windfall. Risks remain

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Medical leaders decry Supreme Court decision on affirmative action

Male doctors called my cancer incurable. A female doctor showed it wasn't

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A preacher's new calling: Diversifying neuroscience research

explore

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Retired US general questions alleged Putin, Prigozhin meeting

Study suggests new cause of Down syndrome: cells linked to aging

Nonprofit, backed by Microsoft, to certify AI tools in health care

Male doctors called my cancer incurable. A female doctor showed it wasn't

FDA early review: GLP

hotspot

focus

explore

Wikipedia